Home/Filings/4/0000950170-25-028040
4//SEC Filing

Khayal Tamer I 4

Accession 0000950170-25-028040

CIK 0001756262other

Filed

Feb 25, 7:00 PM ET

Accepted

Feb 26, 6:07 PM ET

Size

7.0 KB

Accession

0000950170-25-028040

Insider Transaction Report

Form 4
Period: 2025-02-24
Khayal Tamer I
Chief Commercial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-02-24+26,49926,499 total
    Exercise: $77.12Exp: 2035-02-24Common Stock (26,499 underlying)
  • Award

    Common Stock

    2025-02-24+17,60638,449 total
Footnotes (2)
  • [F1]Consists of 17,606 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 24, 2025 until the option is fully vested on February 24, 2029, subject to continued service.

Documents

1 file

Issuer

TransMedics Group, Inc.

CIK 0001756262

Entity typeother

Related Parties

1
  • filerCIK 0001430462

Filing Metadata

Form type
4
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 6:07 PM ET
Size
7.0 KB